Author: apopescu@pmlive.com

Tom O’Leary considers how the Internet of Medical Things (IoMT) is evolving the patient role in pharma

New smart building technologies are helping pharmaceutical companies enhance productivity without compromising on compliance or quality. However, to maximise the available opportunities, companies need to choose the right technology providers, explains Adam Chapman, Vertical Sales Director – Life Sciences (Europe) at Honeywell Building Solutions.

As many as 500 million patients worldwide are suffering from a ‘rare’ disease. This evolving landscape is a growing concern for payers, say Adelphi Values | PROVE

Future commercial models will see radical reorganisation in the coming years